{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:53:08Z","timestamp":1768287188458,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF14OC0013659"],"award-info":[{"award-number":["NNF14OC0013659"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jdiacomp.2024.108923","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T17:17:44Z","timestamp":1733246264000},"page":"108923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Kidney fat by magnetic resonance spectroscopy in type 2 diabetes with chronic kidney disease"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6786-807X","authenticated-orcid":false,"given":"Niels Sondergaard","family":"Heinrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rune Ploegstra","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Bitsch","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrik Bj\u00f8rn","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Haddock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Fornoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik Bo Wiberg","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tine Willum","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2024.108923_bb0005","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0010","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0015","doi-asserted-by":"crossref","DOI":"10.1111\/joim.13214","article-title":"Type 2 diabetes and remission: practical management guided by pathophysiology","volume":"289","author":"Taylor","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0025","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy","volume":"55","author":"Herman-Edelstein","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","article-title":"Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease","volume":"2","author":"de Vries","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrneph.2017.155","article-title":"Dyslipidaemia in nephrotic syndrome: mechanisms and treatment","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0040","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00375.2015","article-title":"Systemic and renal lipids in kidney disease development and progression","volume":"310","author":"Wahl","year":"2016","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0050","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1172\/JCI125316","article-title":"ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes","volume":"129","author":"Ducasa","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0055","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1007\/s00261-022-03603-4","article-title":"MRI-based quantification of renal fat in obese individuals using different image analysis approaches","volume":"47","author":"Gjela","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0060","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jmri.26003","article-title":"(1) H-MRS for the assessment of renal triglyceride content in humans at 3T: a primer and reproducibility study","volume":"48","author":"Dekkers","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0065","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/jmri.25252","article-title":"Quantification of renal steatosis in type II diabetes mellitus using Dixon-based MRI","volume":"44","author":"Yokoo","year":"2016","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0070","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1007\/s00330-017-5298-6","article-title":"Renal fat fraction and diffusion tensor imaging in patients with early-stage diabetic nephropathy","volume":"28","author":"Wang","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0075","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s00330-015-3703-6","article-title":"Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis","volume":"25","author":"Kukuk","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216635","article-title":"Renal and renal sinus fat volumes as quantified by magnetic resonance imaging in subjects with prediabetes, diabetes, and normal glucose tolerance","volume":"15","author":"Notohamiprodjo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10334-019-00773-z","article-title":"Renal sinus fat and renal hemodynamics: a cross-sectional analysis","volume":"33","author":"Spit","year":"2020","journal-title":"Magma"},{"issue":"9","key":"10.1016\/j.jdiacomp.2024.108923_bb0090","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1111\/dom.15146","article-title":"Evaluation of the effects of ezetimibe on albuminuria and kidney fat in individuals with type 2 diabetes and chronic kidney disease","volume":"25","author":"Heinrich","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0095","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062209","article-title":"Metabolic imaging of human kidney triglyceride content: reproducibility of proton magnetic resonance spectroscopy","volume":"8","author":"Hammer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0105","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.clnu.2017.04.007","article-title":"Changes of renal sinus fat and renal parenchymal fat during an 18-month randomized weight loss trial","volume":"37","author":"Zelicha","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/nu14071437","article-title":"Changes in kidney fat upon dietary-induced weight loss","volume":"14","author":"Spurny","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.jrn.2020.09.006","article-title":"The effect of glycemic control on renal triglyceride content assessed by proton spectroscopy in patients with type 2 diabetes mellitus: a single-center parallel-group trial","volume":"31","author":"Dekkers","year":"2021","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176358","article-title":"Novel insights and mechanisms of lipotoxicity-driven insulin resistance","volume":"21","author":"Lair","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0130","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0135","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications","volume":"398","author":"Brown","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0140","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S2213-8587(21)00179-0","article-title":"Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial","volume":"9","author":"Neeland","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.jdiacomp.2024.108923_bb0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S2213-8587(22)00008-0","article-title":"Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial","volume":"10","author":"Kadowaki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082150","article-title":"Effect of SGLT2-inhibitors on Epicardial adipose tissue: a Meta-analysis","volume":"10","author":"Masson","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.jdiacomp.2024.108923_bb0155","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2468-1253(21)00261-2","article-title":"Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review","volume":"7","author":"Mantovani","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102562","article-title":"Effect of glucagon-like peptide-1 (GLP-1) analogues on epicardial adipose tissue: a meta-analysis","volume":"16","author":"Berg","year":"2022","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2147\/DMSO.S289712","article-title":"Empagliflozin regulates the AdipoR1\/p-AMPK\/p-ACC pathway to alleviate lipid deposition in diabetic nephropathy","volume":"14","author":"Zhang","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0170","article-title":"The sodium-glucose cotransporter 2 inhibitor Dapagliflozin prevents renal and liver disease in Western diet induced obesity Mice","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0175","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1074\/jbc.M117.779520","article-title":"SGLT2 protein expression is increased in human diabetic nephropathy: SGLT2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of nephropathy in diabetic mice","volume":"292","author":"Wang","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104778","article-title":"Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis","volume":"156","author":"Su","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0185","doi-asserted-by":"crossref","first-page":"F181","DOI":"10.1152\/ajprenal.00302.2017","article-title":"Glucagon-like peptide-1 analog prevents obesity-related glomerulopathy by inhibiting excessive autophagy in podocytes","volume":"314","author":"Guo","year":"2018","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0190","article-title":"Lipidomic analysis reveals the protection mechanism of GLP-1 analogue dulaglutide on high-fat diet-induced chronic kidney disease in Mice","volume":"12","author":"Yeung","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0195","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.2337\/dc22-S011","article-title":"11. Chronic kidney disease and risk management: standards of medical care in diabetes-2022","volume":"45","author":"Draznin","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00125-019-05039-w","article-title":"2019 update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"63","author":"Buse","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0205","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","author":"KDIGO","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0210","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/ndt\/gfx243","article-title":"Metabolic imaging of fatty kidney in diabesity: validation and dietary intervention","volume":"33","author":"Jonker","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12050386","article-title":"In vivo renal lipid quantification by accelerated magnetic resonance spectroscopic imaging at 3T: feasibility and reliability study","volume":"12","author":"Alhulail","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0220","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2024.108923_bb0225","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2337\/dc07-1463","article-title":"Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects","volume":"31","author":"Kotronen","year":"2008","journal-title":"Diabetes Care"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724002496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724002496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T11:53:26Z","timestamp":1739015606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872724002496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1056872724002496"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108923","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney fat by magnetic resonance spectroscopy in type 2 diabetes with chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108923"}}